XENOTHERA to raise Series A

XENOTHERA to raise Series A

Xenothera has started to gather investors for a Series A round of funding that will occur in December 2018.

This upcoming round will finance an highly anticipated first-in-human trial that will take place in 2019. After amazing pre-clinical and toxicology data in 2018, Xenothera’s LIS1 is ready for clinical tests. As per the nature of the product there will be no phase I and we are excited to jump onto the phase II.

Stay tuned for the upcoming publications regarding pre-clinical analysis.

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *